Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,470 | 329 | 86.5% |
| Honoraria | $1,000 | 1 | 13.4% |
| Education | $13.89 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,254 | 84 | $0 (2024) |
| AltaThera Pharmaceuticals LLC | $1,168 | 2 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $656.70 | 22 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $577.37 | 9 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $525.92 | 35 | $0 (2024) |
| Amgen Inc. | $429.18 | 35 | $0 (2023) |
| Merck Sharp & Dohme LLC | $427.34 | 20 | $0 (2024) |
| PFIZER INC. | $393.53 | 25 | $0 (2024) |
| Boston Scientific Corporation | $347.88 | 20 | $0 (2024) |
| Abbott Laboratories | $206.50 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,185 | 88 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($351.21) |
| 2023 | $2,706 | 82 | AltaThera Pharmaceuticals LLC ($1,168) |
| 2022 | $1,233 | 74 | Novartis Pharmaceuticals Corporation ($367.30) |
| 2021 | $1,359 | 87 | Novartis Pharmaceuticals Corporation ($219.60) |
All Payment Transactions
331 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $1.49 | General |
| Category: Cardiovascular | ||||||
| 12/18/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.45 | General |
| Category: Cardiovascular | ||||||
| 12/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Cardio-renal | ||||||
| 12/04/2024 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $26.95 | General |
| Category: Medical Device | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/02/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: Genetic Disease | ||||||
| 11/26/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $5.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/22/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Cardio-renal | ||||||
| 11/20/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $9.58 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/04/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: Iron Deficiency Anemia | ||||||
| 11/04/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: Genetic Disease | ||||||
| 10/30/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.02 | General |
| Category: Cardiovascular | ||||||
| 10/30/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $0.87 | General |
| Category: Cardiovascular | ||||||
| 10/28/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $123.87 | General |
| Category: Cardiovascular | ||||||
| 10/28/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Obesity | ||||||
| 10/24/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $1.63 | General |
| Category: Cardiovascular | ||||||
| 10/22/2024 | Boston Scientific Corporation | RESONATE EL ICD VR (Device) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: RESONATE_CRM | ||||||
| 10/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $8.29 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/25/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $8.42 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/23/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 2,055 | 2,697 | $416,314 | $110,212 |
| 2022 | 7 | 1,636 | 2,150 | $307,744 | $84,726 |
| 2021 | 3 | 513 | 551 | $73,968 | $25,971 |
| 2020 | 5 | 571 | 610 | $82,879 | $20,707 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 691 | 945 | $226,800 | $69,842 | 30.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 468 | 545 | $89,925 | $28,130 | 31.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 710 | 1,007 | $87,609 | $8,173 | 9.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 110 | 115 | $11,385 | $3,504 | 30.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 76 | 85 | $595.00 | $563.56 | 94.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 431 | 584 | $140,160 | $46,515 | 33.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 405 | 472 | $77,880 | $26,016 | 33.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 600 | 872 | $75,864 | $7,584 | 10.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 77 | 80 | $7,920 | $2,790 | 35.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 18 | 19 | $3,135 | $890.10 | 28.4% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 13 | 13 | $2,015 | $609.32 | 30.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 92 | 110 | $770.00 | $322.14 | 41.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 212 | 225 | $37,200 | $17,797 | 47.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 48 | 49 | $11,025 | $5,659 | 51.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 253 | 277 | $25,743 | $2,515 | 9.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 248 | 264 | $43,560 | $14,654 | 33.6% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 270 | 293 | $27,249 | $2,614 | 9.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 29 | 29 | $6,525 | $2,461 | 37.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 13 | 13 | $1,508 | $529.97 | 35.1% |
| 93015 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report | Office | 2020 | 11 | 11 | $4,037 | $447.59 | 11.1% |
About Christi Wiggins, APRN, NP-C
Christi Wiggins, APRN, NP-C is a Family healthcare provider based in West Columbia, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/08/2019. The National Provider Identifier (NPI) number assigned to this provider is 1346705837.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Christi Wiggins, APRN, NP-C has received a total of $7,484 in payments from pharmaceutical and medical device companies, with $2,185 received in 2024. These payments were reported across 331 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($6,470).
As a Medicare-enrolled provider, Wiggins has provided services to 4,775 Medicare beneficiaries, totaling 6,008 services with total Medicare billing of $241,616. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Family
- Other Specialties Adult Health
- Location West Columbia, SC
- Active Since 02/08/2019
- Last Updated 09/16/2021
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1346705837
Products in Payments
- Sotalol Hydrochloride (Drug) $1,168
- ENTRESTO (Drug) $676.29
- LEQVIO (Drug) $577.64
- LifeVest (Device) $577.37
- ELIQUIS (Drug) $431.60
- Repatha (Biological) $429.18
- VERQUVO (Drug) $427.34
- FARXIGA (Drug) $320.27
- CAMZYOS (Drug) $274.11
- WATCHMAN Access System (Device) $226.41
- VYNDAQEL (Drug) $210.88
- XARELTO (Drug) $190.18
- MITRACLIP (Device) $184.46
- Inpefa (Drug) $138.09
- BRILINTA (Drug) $125.10
- FUROSCIX (Drug) $121.47
- INJECTAFER (Drug) $118.10
- ONPATTRO (Drug) $118.06
- WAINUA (Drug) $107.03
- JARDIANCE (Drug) $105.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in West Columbia
Rachel Hanes, Dnp, Aprn, DNP, APRN
Family — Payments: $6,201
Mrs. Regina Rouse, Fnp, FNP
Family — Payments: $6,117
Rebecca Reed, Fnp-Bc, FNP-BC
Family — Payments: $4,290
Cecilia Porcher, Fnp, FNP
Family — Payments: $4,182
Mrs. Susan Drinkwater
Family — Payments: $3,793
Kathleen Baxley, Fnp-Bc, FNP-BC
Family — Payments: $3,681